Month: February 2021

Monopar Announces First Patient Dosed in its Phase 2b/3 VOICE Trial Evaluating Validive® for the Prevention of Chemoradiotherapy-Induced Severe Oral Mucositis (SOM) in Oropharyngeal Cancer (OPC)

There are currently no FDA-approved drugs to prevent or treat chemoradiotherapy-induced SOMWILMETTE, Ill., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Monopar...

OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Best Practice Techniques for AI-powered Prediction of Antibiotic Susceptibility Testing by Next-Generation Sequencing

Study highlights best practice techniques for accurate antimicrobial resistance prediction from whole-genome sequencing data Publication supports harmonization of the development...

OmniSYS Scales IT Capacity with Virtustream Enterprise Cloud to Meet Record-Setting Demands of U.S. Pharmacies Managing COVID-19 Vaccines

MCLEAN, Va.--(BUSINESS WIRE)--Virtustream, an enterprise-class cloud company and a Dell Technologies business, announced today that OmniSYS, a Dallas-based healthcare technology...

Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatients

Press release Synairgen plc(‘Synairgen’ or the ‘Company’)                                           Synairgen announces that dosing has commenced with its inhaled interferon beta product in...

error: Content is protected !!